Found 34 matching trials
Apixaban vs Rivaroxaban vs No Anticoagulant to Prevent EHIT After Great Saphenous Vein Laser Ablation
PHASE4Endothermal heat-induced thrombosis (EHIT) is a thrombotic complication spe...
Location
Heart Artery and Vein Center of Fresno
Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis
PHASE4The randomized clinical study aimed to assess the efficacy and safety of st...
Location
Clinical Hospital no.1 of the President's Administration of Russian Federation
BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects
PHASE1The objective of this study was to compare the pharmacokinetic profiles and...
Location
Jeonbuk National University Hospital
NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
PHASE4The goal of this clinical trial is to compare short-term Triple Antithrombo...
Location
Chinese Academy of Medical Sciences, Fuwai Hospital
Influence of Rivaroxaban for Intermittent Claudication and Exercise Tolerance in Patients With Symptomatic PAD
N/AThe aim of the conducted research is to evaluate the protective effect of r...
Location
Multiple Locations
AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)
PHASE4Patients without a documented history of Atrial Fibrillation (AF) and will ...
Location
Sharp Memorial Hospital
Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
PHASE3In renally impaired patients with acute venous thromboembolism (VTE), stand...
Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients
PHASE3Atrial fibrillation is the most frequent cardiac rhythm disorder and its pr...
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
PHASE3The primary goal of the trial is to determine if the experimental arms (riv...
Status
Active Not Recruiting
Location
University of Alabama Hospital
Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF
PHASE3APERITIF is a prospective randomized open-label, blinded end-point (PROBE) ...